Phase 1 Metabolic Dysfunction-Associated Steatotic Liver Disease Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis

Regeneron Pharmaceuticals132 enrolled3 locationsNCT06836609

Recruiting

Phase 1

Developing Microbial Therapy for MASLD: From Mechanism to Clinical Validation

Metabolic Dysfunction-Associated Steatotic Liver Disease

Leeuwenhoek Laboratories Co. Ltd.40 enrolled1 locationNCT07488975

Recruiting

Phase 1

COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study

MenopauseMetabolic Dysfunction-Associated Steatotic Liver Disease

University of Oxford10 enrolled1 locationNCT06704516